A study claims collagen makes you "1.4 years biologically younger" — here's how to read the fine print

A real, peer-reviewed study with a headline built to sell you something — and a walkthrough of exactly how to tell whether a claim like it holds up.

How to read a supplement study in four questions

This is the most useful skill we can give you, because you'll use it for the rest of your life. When a product cites "a peer-reviewed study," ask:

1. Was there a control group? A study where everyone got the supplement (a "single-arm" or observational study) can't tell you the supplement did anything — people change over months for a hundred reasons. The gold standard is randomized, placebo-controlled, blinded: some get the real thing, some get a dummy, and nobody knows who.

2. Who funded it, and who ran it? A study paid for by the company selling the product isn't disqualified — but it earns extra scrutiny, especially if the company also measured the outcome.

3. What exactly was tested? If the product has five ingredients, a result can't be credited to the one on the label.

4. How big, how long, and how was "success" measured? Small, short, and a noisy or subjective outcome measure all weaken a finding.

Why there's no regulator to point to on collagen

Still no move from the FDA on peptides — the six recommended in July remain in the gray zone: not banned, not approved-for-compounding, not FDA-approved. But here's the connection to today's story: collagen is a dietary supplement, not a drug — which means it never goes through FDA review for whether it works. Supplements are regulated for safety and labeling, not efficacy.

So for a supplement, there is no FDA verdict to point to — which is precisely why a company-funded study becomes the "proof" in the marketing. When there's no regulator checking the claim, the study is doing all the persuasive work, and you have to be your own reviewer. Hence this week's lesson.

The study, run through the four questions

In November 2025, the journal npj Aging published a paper with an irresistible title: collagen amino-acid supplementation "reduces biological age in humans." The specific claim: participants were 1.4 years biologically younger after six months (p=0.04). It's a real, peer-reviewed, open-access paper — and it's already ideal marketing fuel.

1. Was there a control group? No — and this is the big one. The human portion was an observational, single-arm study: every participant got the product, measured before and after. No placebo, no randomization, no blinding. That design can establish safety, but it essentially cannot establish that the supplement caused anything, because it can't separate the product from everything else that happens over six months.

2. Who funded it, and who measured the result? The product is owned by a supplement company that funded the study and holds the patent, and the paper's senior author is a co-founder and shareholder. The "biological age" was measured by a saliva epigenetic test whose own two co-founders are authors on the paper and personally ran the analysis. So the company selling the supplement paid for a study of its own product, and the company selling the age-test produced the flattering number. (To the authors' credit, all of this is openly disclosed — but disclosure doesn't make the conflict disappear; it just lets you see it.)

3. What exactly was tested? Not "collagen." The product was a multi-ingredient formula that also contains vitamin C, astaxanthin, and calcium alpha-ketoglutarate — each independently promoted for skin or aging. Even if something real happened, you cannot attribute it to collagen.

4. How big, how long, how measured? They screened 102 people; only 45 completed the biological-age test, and daily adherence fell from 86% to 52% by month six. In a single-arm study, the people who quit aren't random — those who feel nothing drop out — which quietly biases the survivors toward looking good. The outcome was a consumer epigenetic "age" clock, which has substantial test-retest noise; a 1.4-year swing sits comfortably inside that wobble. The result was p=0.04 — barely over the line. And the authors themselves flag regression to the mean (the people who "improved most" were those with the worst starting scores — exactly what statistical noise produces).

The keeper concept: this isn't a "bad" or fraudulent study — it's an honestly-reported weak one, and the paper says so in its own fine print. The dishonesty, when it comes, will happen downstream — in the ad that says "peer-reviewed study proves collagen reverses aging by 1.4 years" and drops every caveat. Your defense isn't distrusting all science; it's knowing the four questions, so the headline and the fine print can't be sold to you as the same thing.

So should a midlife woman take collagen?

Here's the honest answer, separated cleanly from this week's overclaim. Because this is important: this study being weak does not mean collagen does nothing. Those are two different questions, and conflating them is its own error.

What collagen actually has reasonable evidence for (from other, better-controlled trials we've covered before): modest improvements in skin hydration and elasticity, and some support for postmenopausal bone density. That evidence is real but modest — "a reasonable, low-risk add-on," not a transformation. If you take a collagen supplement for your skin and you like it, there's a defensible basis for that, and it's cheap and safe.

What collagen does not have evidence for is the thing this week's headline sells: making you measurably, biologically younger. That claim rests on the single weakest study in the stack, funded and measured by the people selling it. The gap between "modestly helps skin" and "reverses your biological age" is exactly the gap between the evidence and the marketing — and midlife women are the precise target for that leap, because "biologically younger" is the most seductive promise in the entire wellness aisle.

The through-line, one more time: the more impressive and more measurable-sounding the claim ("1.4 years younger," a specific number, from a test), the more it pays to ask who ran the test and whether there was a control group. Objective-sounding is not the same as objective. Take the collagen for your skin if you like it; don't buy the age-reversal story — and now you know exactly how to tell the two apart.

Educational, not medical advice. Always consult a qualified clinician before starting, stopping, or changing any treatment. Regulatory details current as of writing and subject to change.

← All issues